Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
OBJECTIVE This study evaluated the association of time in range (TIR) of 70–180 mg/dL (3.9–10 mmol/L) with the development or progression of retinopathy and development of microalbuminuria using the Diabetes Control and Complications Trial (DCCT) data set in order to validate the use of TIR as an ou...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | 英语 |
| 出版: |
2018
|
| 在線閱讀: | https://doi.org/10.2337/dc18-1444 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|